Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, and Lung Cancer Treatments and Mutations.
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
Discovery of a novel shared tumor antigen in human lung cancer.
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors